Listeria monocytogenes Brain Abscess: Controversial Issues for the Treatment-Two Cases and Literature Review.
Beatrice TiriGiulia PrianteLavinia Maria SaracaLucia Assunta MartellaStefano CappaneraDaniela FrancisciPublished in: Case reports in infectious diseases (2018)
Listeria monocytogenes (LM) is an opportunistic pathogen, and the most common central nervous system manifestation is meningitis while listerial brain abscesses are rare. We describe 2 cases of brain abscess due to LM and a literature review. Only 73 cases were reported in the literature from 1968 to 2017. The mean age was 51.9, and the mortality rate was 27.3%. In 19% of cases, no risk factors for neurolisteriosis were identified. Blood cultures were positive in 79.5% while CSF or brain abscess biopsy material was positive in 50.8%. In 40% was started a monotherapy regimen while in 60% a combination therapy without substantial differences in mortality. Fifty-two percent underwent neurosurgery while 45.3% has been treated only with medical therapy. The mortality rates were, respectively, 13% and 38.2%. Only 25% of patients who were treated for ≤6 weeks underwent neurosurgery, while 80% of those who were treated for ≥8 weeks were operated. The mortality rates were, respectively, 12.5% and 0%, suggesting that a combined approach of surgery and prolonged medical therapy would have an impact on mortality. We believe that it is essential to carry out this review as brain abscesses are rare, and there are no definitive indications on the optimal management, type, and duration of therapy.
Keyphrases
- combination therapy
- resting state
- listeria monocytogenes
- white matter
- cardiovascular events
- functional connectivity
- risk factors
- cerebral ischemia
- case report
- type diabetes
- multiple sclerosis
- clinical trial
- squamous cell carcinoma
- radiation therapy
- bone marrow
- open label
- brain injury
- study protocol
- blood brain barrier
- replacement therapy
- smoking cessation